Protocol Ledger

NCT03636295 · Phase III · RECRUITING

Low INR to Minimize Bleeding With Mechanical Valves Trial

Interventional Phase III clinical trial protocol NCT03636295 sponsored by Population Health Research Institute in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-09-05 Enrollment: 2,625 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03636295
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)2,625 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03636295
Protocol FieldVerified Registry Value
NCT IdentifierNCT03636295
Consolidated Lead SponsorPopulation Health Research Institute
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment2,625 participants (ESTIMATED)
Registered Start Date2019-09-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03636295
Hospital Research SiteLocationSite Profile
Universitair Ziekenhuis LeuvenLeuven, BelgiumOpen Hospital Dossier ->
Jewish General HospitalMontreal, CanadaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI